Abby's

Volume 12, Issue 3

Issue link: https://cp.revolio.com/i/1522027

Contents of this Issue

Navigation

Page 28 of 35

www.AbbysHealthFood.com | # 63| Page 29 By Dr. Mark Stengler NDMD Cholesterol-lowering statin drugs are among the most common prescriptions in the United States. Side effects such as muscle and joint pain, fatigue, cognitive problems, and elevated glucose levels are a concern. Moreover, some research has called into question the effectiveness of these medications in reducing cardiovascular outcomes and death. Bergamot is a relatively new dietary supplement used to balance levels and improve cardiovascular health. This fruit grows in the regions of Southern Italy and South-East Asia. Bergamot extracts utilize flavonoid extracts from this fruit for balancing lipid levels. Published research has documented that bergamot extract supplements have the following benefits: Anti-inflammatory Anti-oxidative Reduces biomarkers used to detect vascular damage Lipid-lowering Increases HDL Improves LDL particle size Reduces atherosclerosis (carotid artery study) Improves insulin sensitivity and improved blood glucose One studied form of bergamot extract, known as Bergavit™, was shown in a six-month study to lower total cholesterol, LDL cholesterol, and triglycerides significantly. Moreover, one of the unique features of bergamot extract is that it can reduce the small density lipoprotein particles, which more readily penetrate the arterial wall and lead to plaque buildup. In addition, the same extract was shown to reduce plaque found Balance Your Cholesterol with B E R G A M O T + in the carotid arteries significantly, as demonstrated by ultrasound diagnostics. Emerald Labs has the Bergavit™ extract in their Bergamot + supplement in the same dose as the study I previously summarized. In addition, the supplement contains a synergistic blend of cardiovascular- healthy nutrients, including pomegranate extract, Camu Camu, and amla fruit extract. References Byrne P, Demasi M, Jones M, Smith SM, O'Brien KK, DuBroff R. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis. JAMA Intern Med. 2022;182(5):474– 481. doi:10.1001/ jamainternmed.2022.0134

Articles in this issue

Links on this page

Archives of this issue

view archives of Abby's - Volume 12, Issue 3